tradingkey.logo
搜索

AVITA Medical Inc

RCEL
添加自选
5.060USD
+0.390+8.35%
收盘 07/02, 13:00美东报价延迟15分钟
155.73M总市值
亏损市盈率 TTM

关于 AVITA Medical Inc 公司

AVITA Medical, Inc. is a therapeutic acute wound care company. The Company’s technologies optimize wound healing, effectively accelerating the time to patient recovery. At the forefront of its platform is the RECELL System for the treatment of thermal burn wounds and full-thickness skin defects. RECELL harnesses the healing properties of a patient’s own skin to create Spray-On Skin Cells, offering a solution for improved clinical outcomes at the point-of-care. In the United States, it also holds the exclusive rights to market, sell, and distribute Cohealyx, an AVITA Medical-branded collagen-based dermal matrix, and PermeaDerm, a biosynthetic wound matrix. Its technologies are designed to optimize skin restoration procedures, effectively accelerating patient healing and recovery. Its solutions improve the healing outcomes for patients with traumatic injuries and surgical repairs, addressing critical healing needs that arise from unpredictable and life-changing events.

AVITA Medical Inc简介

公司代码RCEL
公司名称AVITA Medical Inc
上市日期Mar 18, 2012
CEOVance (Cary G)
员工数量260
证券类型Ordinary Share
年结日Mar 18
公司地址28159 Avenue Stanford
城市VALENCIA
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编91355
电话16613679170
网址https://www.avitamedical.com/
公司代码RCEL
上市日期Mar 18, 2012
CEOVance (Cary G)

AVITA Medical Inc公司高管

名称
名称/职务
职务
持股
持股变动
Prof. Suzanne Crowe
Prof. Suzanne Crowe
Independent Non-Executive Director
Independent Non-Executive Director
46.93K
-6.37%
Mr. Jeremy Curnock Cook
Mr. Jeremy Curnock Cook
Independent Non-Executive Director
Independent Non-Executive Director
39.84K
-7.51%
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Non-Executive Lead Independent Director
Non-Executive Lead Independent Director
--
--
Mr. Cary G. Vance
Mr. Cary G. Vance
Chairman of the Board, Interim Chief Executive Officer
Chairman of the Board, Interim Chief Executive Officer
--
--
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. David O'Toole
Mr. David O'Toole
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Jessica Ekeberg
Ms. Jessica Ekeberg
Director - Investor Relations
Director - Investor Relations
--
--
Ms. Nicole Linda Kelsey, J.D.
Ms. Nicole Linda Kelsey, J.D.
Chief Legal and Compliance Officer, Corporate Secretary
Chief Legal and Compliance Officer, Corporate Secretary
--
--
Dr. Michael Tarnoff Tarnoff, M.D.
Dr. Michael Tarnoff Tarnoff, M.D.
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Prof. Suzanne Crowe
Prof. Suzanne Crowe
Independent Non-Executive Director
Independent Non-Executive Director
46.93K
-6.37%
Mr. Jeremy Curnock Cook
Mr. Jeremy Curnock Cook
Independent Non-Executive Director
Independent Non-Executive Director
39.84K
-7.51%
Ms. Jan Stern Reed
Ms. Jan Stern Reed
Non-Executive Lead Independent Director
Non-Executive Lead Independent Director
--
--
Mr. Cary G. Vance
Mr. Cary G. Vance
Chairman of the Board, Interim Chief Executive Officer
Chairman of the Board, Interim Chief Executive Officer
--
--
Mr. Robert E. Mcnamara
Mr. Robert E. Mcnamara
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. David O'Toole
Mr. David O'Toole
Chief Financial Officer
Chief Financial Officer
--
--

常见问题

AVITA Medical Inc的前五大股东是谁?

AVITA Medical Inc 的前五大股东如下:Prof. Suzanne Crowe

有多少机构持有AVITA Medical Inc(RCEL)的股份?

截至2026Q1,共有209家机构持有AVITA Medical Inc的股份,合计持有的股份价值约为6.52M,占公司总股份的21.20%。与2025Q4相比,机构持股有所增加,增幅为-1392153.00。